Literature DB >> 9389731

Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.

C Napoli1, F P D'Armiento, F P Mancini, A Postiglione, J L Witztum, G Palumbo, W Palinski.   

Abstract

To determine whether oxidized LDL enhances atherogenesis by promoting monocyte recruitment into the vascular intima, we investigated whether LDL accumulation and oxidation precede intimal accumulation of monocytes in human fetal aortas (from spontaneous abortions and premature newborns who died within 12 h; fetal age 6.2+/-1.3 mo). For this purpose, a systematic assessment of fatty streak formation was carried out in fetal aortas from normocholesterolemic mothers (n = 22), hypercholesterolemic mothers (n = 33), and mothers who were hypercholesterolemic only during pregnancy (n = 27). Fetal plasma cholesterol levels showed a strong inverse correlation with fetal age (R = -0.88, P < 0.0001). In fetuses younger than 6 mo, fetal plasma cholesterol levels correlated with maternal ones (R = 0.86, P = 0.001), whereas in older fetuses no such correlation existed. Fetal aortas from hypercholesterolemic mothers and mothers with temporary hypercholesterolemia contained significantly more and larger lesions (758,651+/-87,449 and 451,255+/-37,448 micron2 per section, respectively; mean+/-SD) than aortas from normocholesterolemic mothers (61,862+/-9,555 micron2; P < 0.00005). Serial sections of the arch, thoracic, and abdominal aortas were immunostained for recognized markers of atherosclerosis: macrophages, apo B, and two different oxidation-specific epitopes (malondialdehyde- and 4-hydroxynonenal-lysine). Of the atherogenic sites that showed positive immunostaining for at least one of these markers, 58.6% were established lesions containing both macrophage/foam cells and oxidized LDL (OxLDL). 17.3% of all sites contained only native LDL, and 13.3% contained only OxLDL without monocyte/ macrophages. In contrast, only 4.3% of sites contained isolated monocytes in the absence of native or oxidized LDL. In addition, 6.3% of sites contained LDL and macrophages but few oxidation-specific epitopes. These results demonstrate that LDL oxidation and formation of fatty streaks occurs already during fetal development, and that both phenomena are greatly enhanced by maternal hypercholesterolemia. The fact that in very early lesions LDL and OxLDL are frequently found in the absence of monocyte/macrophages, whereas the opposite is rare, suggests that intimal LDL accumulation and oxidation contributes to monocyte recruitment in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389731      PMCID: PMC508471          DOI: 10.1172/JCI119813

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

Review 1.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta.

Authors:  J GLAVIND; S HARTMANN; J CLEMMESEN; K E JESSEN; H DAM
Journal:  Acta Pathol Microbiol Scand       Date:  1952

3.  The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins).

Authors:  S Hörkkö; E Miller; D W Branch; W Palinski; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

4.  Lipids of human atheroma. 4. Characterisation of a new group of polar sterol esters from human atherosclerotic plaques.

Authors:  C J Brooks; G Steel; J D Gilbert; W A Harland
Journal:  Atherosclerosis       Date:  1971 Mar-Apr       Impact factor: 5.162

Review 5.  Lipid peroxidation in pregnancy: new perspectives on preeclampsia.

Authors:  C A Hubel; J M Roberts; R N Taylor; T J Musci; G M Rogers; M K McLaughlin
Journal:  Am J Obstet Gynecol       Date:  1989-10       Impact factor: 8.661

6.  A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits.

Authors:  J Fruebis; D Steinberg; H A Dresel; T E Carew
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

7.  Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?

Authors:  M Sasahara; E W Raines; A Chait; T E Carew; D Steinberg; P W Wahl; R Ross
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 8.  Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.

Authors:  J A Berliner; M Navab; A M Fogelman; J S Frank; L L Demer; P A Edwards; A D Watson; A J Lusis
Journal:  Circulation       Date:  1995-05-01       Impact factor: 29.690

9.  Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice.

Authors:  R K Tangirala; F Casanada; E Miller; J L Witztum; D Steinberg; W Palinski
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-10       Impact factor: 8.311

10.  Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins.

Authors:  A Hammer; G Kager; G Dohr; H Rabl; I Ghassempur; G Jürgens
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

View more
  185 in total

Review 1.  Immune recognition of OxLDL in atherosclerosis.

Authors:  J F Kearney
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 2.  The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients.

Authors:  C Sarti; M Kaarisalo; J Tuomilehto
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

Review 3.  Did the antioxidant trials fail to validate the oxidation hypothesis?

Authors:  S Parthasarathy; N Khan-Merchant; M Penumetcha; B V Khan; N Santanam
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

4.  Maternal lipids at mid-pregnancy and the risk of preterm delivery.

Authors:  Lanay M Mudd; Claudia B Holzman; Janet M Catov; Patricia K Senagore; Rhobert W Evans
Journal:  Acta Obstet Gynecol Scand       Date:  2012-05-01       Impact factor: 3.636

5.  FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis.

Authors:  Kyoichiro Tsuchiya; Jun Tanaka; Yu Shuiqing; Carrie L Welch; Ronald A DePinho; Ira Tabas; Alan R Tall; Ira J Goldberg; Domenico Accili
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

6.  The role of cardiovascular magnetic resonance in the non-invasive imaging of the atherosclerotic plaque.

Authors:  Anitha Varghese; Marcus Ellington; Guang Zhong Yang; Dudley J Pennell
Journal:  Int J Cardiovasc Imaging       Date:  2003-10       Impact factor: 2.357

7.  Changes in LDL and HDL subclasses in normal pregnancy and associations with birth weight, birth length and head circumference.

Authors:  Aleksandra Zeljkovic; Jelena Vekic; Slavica Spasic; Zorana Jelic-Ivanovic; Vesna Spasojevic-Kalimanovska; Tamara Gojkovic; Daniela Ardalic; Vesna Mandic-Markovic; Nikola Cerovic; Zeljko Mikovic
Journal:  Matern Child Health J       Date:  2013-04

Review 8.  Childhood obesity: a life-long health risk.

Authors:  Matthias Barton
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

Review 9.  Cholesterol in pregnancy: a review of knowns and unknowns.

Authors:  Änne Bartels; Keelin O'Donoghue
Journal:  Obstet Med       Date:  2011-07-28

10.  Maternal mid-pregnancy lipids and birthweight.

Authors:  Lanay M Mudd; Claudia B Holzman; Rhobert W Evans
Journal:  Acta Obstet Gynecol Scand       Date:  2015-05-13       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.